First published 9/28/2026, 4:15:15 PM · Last updated 9/28/2026, 4:15:15 PM

Associations between clot burden measured by refined modified Miller score and cardiac biomarkers in patients with intermediate-high risk pulmonary embolism

A SAGE-published journal article examines associations between clot burden quantified by a refined modified Miller score and cardiac biomarkers in patients with intermediate-high–risk pulmonary embolism. No additional methodological, result, geographic, or sample-size details were provided in the source data.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 3/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article reports clinical research on the relationship between clot burden and cardiac biomarkers in intermediate-high–risk pulmonary embolism.

Sources

Associations between clot burden measured by refined modified Miller score and cardiac biomarkers in patients with intermediate-high risk pulmonary embolism

Report an issue